Their new three-year term will take effect from September 1, 2026, according to the Gazette Notice issued by the Cabinet ...
Community Supported Shelters, which first opened its doors in Lane County in 2013, is opening a brand-new center ...
Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with Non-Obstructive HCM New Analysis of MAPLE-HCM Finds Aficamten Outperformed Meto ...
Additional Results from ACACIA-HCM Demonstrate Improvements in Cardiac Structure and Diastolic Function in Patients with ...
Cytokinetics, Incorporated ( CYTK ), a biopharmaceutical company focused on developing muscle-directed therapies, announced positive results from its pivotal Phase 3 ACACIA-HCM trial of aficamten in ...
For decades, drugmakers have been confounded in the clinic by a rare form of hypertrophic cardiomyopathy. | Cytokinetics' ...
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with ...
ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both ...
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with ...
In what might be the world’s most insulting – but successful – job application ever, digital nomad Jacob Blatch ditched a polite resume for an epic tirade strewn with insults, telling his prospective ...
Key takeawaysThere are currently no approved treatments for symptomatic non-obstructive hypertrophic cardiomyopathy (HCM). The ACACIA-HCM trial ...
A federal rule quietly changed in 2024, and grandparents who still follow the old advice about 529 withdrawals are leaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results